Document Detail


Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
MedLine Citation:
PMID:  17890957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Influence of changes in levels of coagulation factors and anticoagulants on acquired activated protein C (APC) resistance were studied in 40 healthy women during normal pregnancy. Factor VIII (FVIII), von Willebrand factor antigen (VWF:Ag), free protein S (FPS) and protein C were determined at 5-13, 14-26 and 27-40 weeks gestation and more than 6 weeks postpartum. APC anticoagulant activity was determined by measuring the activated partial thromboplastin time before and after adding human APC, expressed as the APC-sensitivity ratio (APC-SR). During the second and third gestation trimesters a significant increase (P < 0.05) in FVIII and VWF:Ag levels and a decrease in FPS levels were seen compared with the first trimester. Postpartum FVIII and VWF:Ag levels significantly decreased and FPS levels increased compared with the third trimester. Protein C levels remained unchanged during pregnancy and postpartum. Between increased FVIII and lowered APC-SR a trend of inverse correlation (r = -0.329; P = 0.076) occurred in the second trimester. No correlation was found between APC-SR and FPS or VWF:Ag levels. A remarkable finding is the strong inverse relationship between APC-SR and protein C levels (r <or= -0.392; P < 0.05) during pregnancy and postpartum. This may indicate that anticoagulant activity of added human APC measured by activated partial thromboplastin time is diminished in the presence of high endogenous protein C levels. A possible hypothesis is steric hindrance by sample protein C of APC binding sites on target activated factor V and/or cofactor protein S. The clinical significance of this finding should be determined because it complicates the interpretation of lowered APC-SR.
Authors:
Boris Mahieu; Nadia Jacobs; Sarah Mahieu; Kristine Naelaerts; Francine Vertessen; Joost Weyler; Yves Jacquemyn; Marc Van der Planken
Related Documents :
10369237 - Computer analysis of the tonic, phasic, and kinesthetic activity of pallidal discharges...
6936067 - N2 fixation in the rhizosphere of thalassia testudinum.
16469937 - Chronic hypoxic decreases in soluble guanylate cyclase protein and enzyme activity are ...
7345727 - In vitro hatching and activation of taenia taeniaeformis oncospheres.
7360447 - Papular dermatitis of pregnancy.
22813367 - Arrhythmias in pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  18     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-24     Completed Date:  2007-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  685-8     Citation Subset:  IM    
Affiliation:
Laboratory of Haemostasis and Haematology, Antwerp University Hospital, Edegem, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activated Protein C Resistance / blood*
Adult
Cross-Sectional Studies
Factor V / analysis
Factor VIII / analysis
Female
Humans
Partial Thromboplastin Time / methods
Pregnancy
Pregnancy Trimesters / blood*
Protein C / analysis*
Protein C Deficiency / blood*
Protein S / analysis
Protein S Deficiency / blood
Risk Factors
von Willebrand Factor / analysis
Chemical
Reg. No./Substance:
0/Protein C; 0/Protein S; 0/von Willebrand Factor; 9001-24-5/Factor V; 9001-27-8/Factor VIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of coagulant activity of factor VII and activated factor VII activity assays when used fo...
Next Document:  Low-dose tenecteplase during cardiopulmonary resuscitation due to massive pulmonary embolism: a case...